White Glove Pharmacy Licensing Logo
Nonresident Pharmacy Licensing

California's Separate Sterile Compounding License

An out-of-state pharmacy that compounds sterile products for California patients needs a nonresident sterile compounding license on top of its California nonresident pharmacy license. The Board inspects before it issues and at least once a year, at the pharmacy's cost, and reviews a year of reports and products first. Here is what Business and Professions Code 4127.2 requires.

← Back to Blog
4 min read · by White Glove Pharmacy Licensing
A gowned pharmacist preparing an IV bag inside a laminar airflow hood in a sterile compounding cleanroom.

California requires a nonresident pharmacy that compounds sterile products for shipment into the state to hold a separate sterile compounding license under B&P 4127.2. It is issued only to a licensed nonresident location's owner, renewed annually, not transferable, and issued only after a Board inspection, which the pharmacy pays for at least once a year.

California treats sterile compounding as its own license. Under Business and Professions Code 4127.2(a), "a nonresident pharmacy shall not compound sterile drug products for shipment into this state without a sterile compounding pharmacy license issued by the board." That license sits on top of the nonresident pharmacy license under section 4112, and since July 1, 2026 the nonresident license itself requires a California-licensed pharmacist-in-charge employed and working at the pharmacy.

Who needs the California nonresident sterile license?

Any pharmacy outside California that compounds sterile drug products and ships them into California. The license is location-specific: it "shall be issued only to a location that is licensed as a nonresident pharmacy and shall be issued only to the owner of the nonresident pharmacy licensed at that location" (4127.2(b)). A pharmacy with two compounding sites needs two nonresident licenses and two sterile licenses.

The license "shall be renewed annually and shall not be transferable" (4127.2(a)). A change of owner means a new license, not an update. See ownership changes and your pharmacy licenses.

What does the Board review before it issues?

Section 4127.2(d) lists four things the Board must have before it issues or renews:

  1. a current copy of the pharmacy's policies and procedures for sterile compounding;
  2. the completed self-assessment form required by section 1735.2 of Title 16 of the California Code of Regulations;
  3. copies of all inspection reports of the premises, and any reports from a private accrediting agency, from the prior 12 months; and
  4. a list of all sterile drug products compounded by the pharmacy within the prior 12 months.

The product list covers what you compounded, not only what you shipped to California, so it should come from your compounding records rather than your California dispensing reports.

How does the California inspection work?

"A license to compound sterile drug products shall not be issued or renewed until the location is inspected by the board and found in compliance" (4127.2(c)). The pharmacy reimburses "all actual and necessary costs incurred by the board in conducting an inspection of the pharmacy at least once annually." The inspection is of your out-of-state location, so the Board's schedule, not yours, sets the date.

Since July 1, 2026, the Board may also inspect any nonresident pharmacy, sterile or not, with the pharmacy depositing the estimated cost when notified (4112(k)). The Board's April 2026 policy statement lists records inspectors expect to see readily available, including past inspection reports, a master list of pharmacists and technicians involved in dispensing for California patients, acquisition and disposition records for drugs dispensed to California patients, medication error reports for California patients, CURES reports for controlled substances, and policies and procedures. The same statement names compounding requirements among the Board's enforcement priorities.

What must a licensed nonresident sterile compounder report?

Section 4127.2(e) and (f) set short reporting clocks:

  • disciplinary or other action by the home state or another state: within 10 days;
  • suspension of any accreditation the pharmacy holds: within 10 days;
  • any recall notice for sterile products shipped into or dispensed in California: within 12 hours;
  • any complaint from a California provider, pharmacy or patient: to be advised to the Board; and
  • adverse effects reported or potentially attributable to the pharmacy's sterile products: within 12 hours to the Board, and immediately to FDA's MedWatch program.

These clocks are far shorter than the 30-day change-reporting windows in Florida, Michigan and Virginia, so a calendar built for 30-day filings will miss them.

How does the PIC rule interact with the sterile license?

The sterile license requires a nonresident pharmacy license, and that license now requires a California-licensed PIC "employed and working at the nonresident pharmacy" (4112(d)). The Board will not require that pharmacist to be your home-state PIC of record, per its April 2026 policy statement. But a sterile compounder cannot get or keep the California sterile license without that pharmacist in place. California uses its own law exam, the CPJE, so the pharmacist's California file usually takes longer than any other state. See California's PIC rule and California's nonresident pharmacy license.

Who prepares the file, and who signs it?

We assemble the California sterile file: policy and procedure cross-references, the self-assessment, the 12-month inspection and accreditation packet, and the product list pulled from your records, and we track the Board's inspection scheduling and the annual renewal. Your officers sign the application under California's signature rules, your pharmacy hosts and pays for the inspection, and your California-licensed PIC remains your own employee. The Sterile Compounding Add-On is $499 per state on top of the $899 complex-state nonresident license. Other states' sterile rules are in nonresident sterile compounding permits by state, and California's page is in our state index.

Common questions

Does California inspect out-of-state sterile compounding pharmacies?
Yes. The Board will not issue or renew the nonresident sterile compounding license until it inspects the location, and the pharmacy reimburses the Board's actual and necessary costs of inspecting at least once a year.
Can a California sterile compounding license be transferred to a buyer?
No. Section 4127.2 says the license shall not be transferable and is issued only to the owner of the licensed nonresident location, so a new owner applies for a new license.
How fast must a recall be reported to the California Board?
Within 12 hours, for any recall notice covering sterile products shipped into or dispensed in California. Adverse effects must also be reported within 12 hours and immediately to FDA's MedWatch program.

Need Help with Pharmacy Licensing?

We prepare every state's nonresident application for your officers and PIC to sign, coordinate your pharmacists' licenses, and track every one to a decision.

Get Started

The fastest way is to call. If you prefer, you can book online below.

817-518-1747
or

Book Online

Share your details and preferred availability.